APC/CY7-Linked Polyclonal Antibody to Protein Kinase, AMP Activated Alpha 2 (PRKAa2)
Cat# MBS2071160-5x5mL
Size : 5x5mL
Brand : MyBiosource
Protein Kinase, AMP Activated Alpha 2 (PRKAa2) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2071160SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2071160 is an antibody targeting PRKAa2. Also known as APC/CY7-Linked Polyclonal Antibody to Protein Kinase, AMP Activated Alpha 2 (PRKAa2). Reactive in Human, Mouse, Rat, Chinese hamster, Dog, Pig, Bovine, Goat, Sheep, Chicken. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Protein Kinase, AMP Activated Alpha 2 (PRKAa2), Polyclonal Antibody
Full Product Name
APC/CY7-Linked Polyclonal Antibody to Protein Kinase, AMP Activated Alpha 2 (PRKAa2)
Product Gene Name
anti-PRKAa2 antibody
Product Synonym Names
AMPK; AMPK2; PRKAA; 5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2; Acetyl-CoA carboxylase kinase; Hydroxymethylglutaryl-CoA reductase kinase
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Chinese hamster, Dog, Pig, Bovine, Goat, Sheep, Chicken
Concentration
>=100ug/ml (lot specific)
Matching Pairs
Unconjugated Antibody: PRKAa2 (MBS2026444)
APC-CY7 Conjugated Antibody: PRKAa2 (MBS2071160)
APC-CY7 Conjugated Antibody: PRKAa2 (MBS2071160)
Matching Pairs
APC-CY7 Conjugated Antibody: PRKAa2 (MBS2071160)
Immunogen: PRKAa2 (MBS2029085)
Immunogen: PRKAa2 (MBS2029085)
Molecular Weight
62,320 Da
OMIM
U06454 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Immunogen
PRKAa2 (Asp252~Ala493)
Conjugation
APC-Cy7
Cross Reactivity
Human, Pig
Unconjugated Antibody
The unconjugated antibody version of this item is also available as catalog #MBS2026444
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-PRKAa2 antibody
Western Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (ELISA)
Other Notes
Small volumes of anti-PRKAa2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for PRKAa2. It may not necessarily be applicable to this product.
NCBI Official Full Name
protein kinase, AMP-activated, alpha 2 catalytic subunit
NCBI Official Synonym Full Names
protein kinase AMP-activated catalytic subunit alpha 2
NCBI Official Symbol
PRKAA2
NCBI Official Synonym Symbols
AMPK; AMPK2; PRKAA; AMPKa2
UniProt Protein Name
5'-AMP-activated protein kinase catalytic subunit alpha-2
UniProt Synonym Protein Names
Acetyl-CoA carboxylase kinase (EC:2.7.11.27
UniProt Gene Name
PRKAA2
UniProt Synonym Gene Names
AMPK; AMPK2; HMGCR kinase
NCBI Protein Information
5'-AMP-activated protein kinase catalytic subunit alpha-2
NCBI Summary for PRKAa2
The protein encoded by this gene is a catalytic subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. Studies of the mouse counterpart suggest that this catalytic subunit may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for PRKAa2
AMPKA2: a catalytic subunit of AMP-activated protein kinase (AMPK). Acts as an energy sensor, playing a key role in regulating cellular energy metabolism. A protein kinase of the CAMKL family whose activation is regulated by the balance between ADP/AMP/ATP, and intracellular Ca(2+) levels. Acts as a metabolic stress-sensing protein kinase switching off biosynthetic pathways when cellular ATP levels are depleted and when 5'-ADP and -AMP rise in response to fuel limitation and/or hypoxia. Activates energy-producing pathways and inhibits energy-consuming processes. Restores ATP levels in cells by switching off anabolic and switching on catabolic pathways. Activated primarily by rising ADP levels and not, as previously thought, solely by AMP. AMPK resembles an adenylate charge regulatory system in which anabolic and catabolic pathways are regulated by adenine nucleotide ratios. Acts via direct phosphorylation of metabolic enzymes and transcription regulators. Regulates fatty acid synthesis by phosphorylating acetyl-CoA carboxylase. Regulates cholesterol synthesis by phosphorylating and inactivating hormone-sensitive lipase and hydroxymethylglutaryl-CoA reductase. Activated by at least two distinct upstream kinases: the tumor suppressor LKB1 and CaMKK2. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton, probably by indirectly activating myosin. AMPK is a heterotrimer of an alpha catalytic subunit (AMPKA1 or -2), a beta (AMPKB1 or -2) and a gamma non-catalytic subunit (AMPKG1, -2 or -3). Different possible combinations of subunits give rise to 12 different holoenzymes. Binding of ADP or AMP to non-catalytic gamma subunit (PRKAG1, -2 or -3) results in allosteric activation. AMPK is activated by antihyperglycemic drug metformin, a drug prescribed to patients with type 2 diabetes: in vivo, metformin seems to mainly inhibit liver gluconeogenesis. However, metformin can be used to activate AMPK in muscle and other cells in culture or ex vivo. Selectively inhibited by compound C (6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-3-pyridin-4-yl-pyyrazolo[1,5-a] pyrimidine. Activated by resveratrol, a natural polyphenol present in red wine, and S17834, a synthetic polyphenol. Salicylate/aspirin directly activates kinase activity. Studies in the mouse suggest that AMPK2 may control whole-body insulin sensitivity and is necessary for maintaining myocardial energy homeostasis during ischemia.
Protein type: AMPK subfamily; Autophagy; CAMK group; CAMKL family; EC 2.7.11.1; EC 2.7.11.27; EC 2.7.11.31; Kinase, protein; Protein kinase, CAMK; Protein kinase, Ser/Thr (non-receptor)
Chromosomal Location of Human Ortholog: 1p32.2
Cellular Component: AMP-activated protein kinase complex; cytoplasm; cytosol; nucleoplasm; nucleus
Molecular Function: AMP-activated protein kinase activity; chromatin binding; histone serine kinase activity; protein binding; protein kinase activity; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity
Biological Process: carnitine shuttle; cell cycle arrest; cellular response to glucose starvation; cellular response to nutrient levels; fatty acid homeostasis; glucose homeostasis; lipid biosynthetic process; macroautophagy; negative regulation of apoptosis; negative regulation of TOR signaling pathway; positive regulation of autophagy; positive regulation of glycolysis; positive regulation of macroautophagy; protein amino acid phosphorylation; regulation of circadian rhythm; regulation of fatty acid biosynthetic process; regulation of macroautophagy; response to stress; signal transduction
Show more Protein type: AMPK subfamily; Autophagy; CAMK group; CAMKL family; EC 2.7.11.1; EC 2.7.11.27; EC 2.7.11.31; Kinase, protein; Protein kinase, CAMK; Protein kinase, Ser/Thr (non-receptor)
Chromosomal Location of Human Ortholog: 1p32.2
Cellular Component: AMP-activated protein kinase complex; cytoplasm; cytosol; nucleoplasm; nucleus
Molecular Function: AMP-activated protein kinase activity; chromatin binding; histone serine kinase activity; protein binding; protein kinase activity; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity
Biological Process: carnitine shuttle; cell cycle arrest; cellular response to glucose starvation; cellular response to nutrient levels; fatty acid homeostasis; glucose homeostasis; lipid biosynthetic process; macroautophagy; negative regulation of apoptosis; negative regulation of TOR signaling pathway; positive regulation of autophagy; positive regulation of glycolysis; positive regulation of macroautophagy; protein amino acid phosphorylation; regulation of circadian rhythm; regulation of fatty acid biosynthetic process; regulation of macroautophagy; response to stress; signal transduction
Research Articles on PRKAa2
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-PRKAa2 antibody
| Reference Product | PubMed Publications |
|---|---|
| PRKAB1 antibody | >18 publications with PRKAa2 and PRKAB1 |
| PRKAG1 antibody | >17 publications with PRKAa2 and PRKAG1 |
| STK11 antibody | >13 publications with PRKAa2 and STK11 |
| PRKAG2 antibody | >9 publications with PRKAa2 and PRKAG2 |
| ACACB antibody | >2 publications with PRKAa2 and ACACB |
| ACACA antibody | >2 publications with PRKAa2 and ACACA |
| TSC2 antibody | >2 publications with PRKAa2 and TSC2 |
| FOXO3 antibody | >1 publications with PRKAa2 and FOXO3 |
| RPTOR antibody | >1 publications with PRKAa2 and RPTOR |
Pathways associated with anti-PRKAa2 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| AMP-activated Protein Kinase (AMPK) Signaling Pathway antibodies | AMP-activated Protein Kinase (AMPK) Signaling Pathway Diagram |
| AMPK Inhibits ChREBP Transcriptional Activation Activity Pathway antibodies | AMPK Inhibits ChREBP Transcriptional Activation Activity Pathway Diagram |
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| AMPK Signaling Pathway antibodies | AMPK Signaling Pathway Diagram |
| Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation Pathway antibodies | Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Angiopoietin Like Protein 8 Regulatory Pathway antibodies | Angiopoietin Like Protein 8 Regulatory Pathway Diagram |
| Autophagy Pathway antibodies | Autophagy Pathway Diagram |
| Autophagy Pathway antibodies | Autophagy Pathway Diagram |
Diseases associated with anti-PRKAa2 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Cardiovascular Diseases Antibodies | >14 publications with PRKAa2 and Cardiovascular Diseases |
| Insulin Resistance Antibodies | >14 publications with PRKAa2 and Insulin Resistance |
| Inflammation Antibodies | >11 publications with PRKAa2 and Inflammation |
| Disease Models, Animal Antibodies | >11 publications with PRKAa2 and Disease Models, Animal |
| Heart Diseases Antibodies | >9 publications with PRKAa2 and Heart Diseases |
| Liver Diseases Antibodies | >7 publications with PRKAa2 and Liver Diseases |
| Fibrosis Antibodies | >5 publications with PRKAa2 and Fibrosis |
| Fatty Liver Antibodies | >5 publications with PRKAa2 and Fatty Liver |
| Adenocarcinoma Antibodies | >5 publications with PRKAa2 and Adenocarcinoma |
| Cardiomyopathies Antibodies | >5 publications with PRKAa2 and Cardiomyopathies |
Organs/Tissues associated with anti-PRKAa2 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Muscle Antibodies | >73 publications with PRKAa2 and Muscle |
| Liver Antibodies | >25 publications with PRKAa2 and Liver |
| Heart Antibodies | >19 publications with PRKAa2 and Heart |
| Brain Antibodies | >10 publications with PRKAa2 and Brain |
| Pancreas Antibodies | >8 publications with PRKAa2 and Pancreas |
| Lung Antibodies | >8 publications with PRKAa2 and Lung |
| Ovary Antibodies | >5 publications with PRKAa2 and Ovary |
| Embryonic Tissue Antibodies | >3 publications with PRKAa2 and Embryonic Tissue |
| Kidney Antibodies | >3 publications with PRKAa2 and Kidney |
| Intestine Antibodies | >2 publications with PRKAa2 and Intestine |


